Blood filter aims to suck cancer cells out of patients with advanced tumors
NCT ID NCT06655142
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called ONCObind that filters cancer cells from the blood of people with advanced pancreatic or colorectal cancer that has not responded to standard treatments. About 120 adults will receive the filtering procedure multiple times to see if it is safe and can reduce the number of tumor cells in the bloodstream. The goal is to improve survival and quality of life, but this is an early feasibility trial, not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Heating the body to fight pancreatic cancer: a new trial tests Whole-Body hyperthermia
- New drug combo targets Hard-to-Treat cancers with specific gene deletion
- Experimental drug combo targets Hard-to-Treat GI cancers
- Could a pill help the liver regrow and make more cancer surgeries possible?
- Can a smaller dose of this cancer drug still work? new trial aims to find out